Zhejiang Hisoar Pharmaceutical Co Ltd (002099) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.48 Million ≈ $2.27 Million USD) by net assets (CN¥5.11 Billion ≈ $747.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002099 net asset quality score to measure how much of total assets are equity-financed.

Zhejiang Hisoar Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)

This chart illustrates how Zhejiang Hisoar Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Zhejiang Hisoar Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Zhejiang Hisoar Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Hisoar Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Henan Thinker Automation SHG:603508	0.027x
TTW Public Company Limited BK:TTW	0.045x
Zotye Automobile Co Ltd SHE:000980	1.703x
Shanghai Luoman Lighting Technologies Inc. SHG:605289	0.015x
Yapp Automotive Systems Co Ltd SHG:603013	0.242x
Wuhan East Lake High Technology Group Co Ltd SHG:600133	-0.006x
Pabrik Kertas Tjiwi Kimia Tbk JK:TKIM	-0.011x
Nolato AB (publ) ST:NOLA-B	0.038x

Annual Cash Flow Conversion Efficiency for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see 002099 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥5.13 Billion ≈ $750.95 Million	CN¥174.83 Million ≈ $25.58 Million	0.034x	-20.66%
2023-12-31	CN¥5.60 Billion ≈ $819.71 Million	CN¥240.54 Million ≈ $35.20 Million	0.043x	+125.81%
2022-12-31	CN¥6.10 Billion ≈ $893.34 Million	CN¥116.09 Million ≈ $16.99 Million	0.019x	+13.58%
2021-12-31	CN¥6.11 Billion ≈ $894.62 Million	CN¥102.36 Million ≈ $14.98 Million	0.017x	-81.65%
2020-12-31	CN¥5.85 Billion ≈ $856.34 Million	CN¥533.87 Million ≈ $78.12 Million	0.091x	-14.72%
2019-12-31	CN¥5.72 Billion ≈ $837.67 Million	CN¥612.40 Million ≈ $89.61 Million	0.107x	-27.14%
2018-12-31	CN¥5.39 Billion ≈ $788.81 Million	CN¥791.45 Million ≈ $115.81 Million	0.147x	+635.28%
2017-12-31	CN¥5.14 Billion ≈ $752.44 Million	CN¥102.68 Million ≈ $15.02 Million	0.020x	-84.87%
2016-12-31	CN¥4.77 Billion ≈ $698.05 Million	CN¥629.42 Million ≈ $92.10 Million	0.132x	+2.00%
2015-12-31	CN¥3.57 Billion ≈ $522.81 Million	CN¥462.16 Million ≈ $67.63 Million	0.129x	+114.65%
2014-12-31	CN¥3.18 Billion ≈ $465.15 Million	CN¥191.56 Million ≈ $28.03 Million	0.060x	-37.33%
2013-12-31	CN¥632.80 Million ≈ $92.60 Million	CN¥60.85 Million ≈ $8.90 Million	0.096x	-60.73%
2012-12-31	CN¥738.05 Million ≈ $108.00 Million	CN¥180.73 Million ≈ $26.45 Million	0.245x	+94.84%
2011-12-31	CN¥736.96 Million ≈ $107.84 Million	CN¥92.62 Million ≈ $13.55 Million	0.126x	-55.67%
2010-12-31	CN¥638.04 Million ≈ $93.36 Million	CN¥180.88 Million ≈ $26.47 Million	0.283x	+61.88%
2009-12-31	CN¥561.79 Million ≈ $82.21 Million	CN¥98.38 Million ≈ $14.40 Million	0.175x	+213.25%
2008-12-31	CN¥547.50 Million ≈ $80.12 Million	CN¥30.61 Million ≈ $4.48 Million	0.056x	-41.18%
2007-12-31	CN¥538.06 Million ≈ $78.73 Million	CN¥51.14 Million ≈ $7.48 Million	0.095x	-20.24%
2006-12-31	CN¥519.27 Million ≈ $75.99 Million	CN¥61.88 Million ≈ $9.06 Million	0.119x	-39.55%
2005-12-31	CN¥182.96 Million ≈ $26.77 Million	CN¥36.07 Million ≈ $5.28 Million	0.197x	-38.55%
2004-12-31	CN¥132.03 Million ≈ $19.32 Million	CN¥42.36 Million ≈ $6.20 Million	0.321x	+600.11%
2003-12-31	CN¥85.03 Million ≈ $12.44 Million	CN¥-5.45 Million ≈ $-798.23K	-0.064x	--

About Zhejiang Hisoar Pharmaceutical Co Ltd

SHE:002099 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.31 Billion

CN¥8.92 Billion CNY

Market Cap Rank

#7675 Global

#1690 in China

Share Price

CN¥5.51

Change (1 day)

+1.10%

52-Week Range

CN¥4.98 - CN¥8.83

All Time High

CN¥11.31